Erratum

The Polyploid State Plays a Tumor-Suppressive Role in the Liver (Developmental Cell (2018) 44(4) (447–459.e5), (S1534580718300108) (10.1016/j.devcel.2018.01.010))

Shuyuan Zhang, Kejin Zhou, Xin Luo, Lin Li, Ho Chou Tu, Alfica Sehgal, Liem H. Nguyen, Yu Zhang, Purva Gopal, Branden D. Tarlow, Daniel J Siegwart, Hao Zhu

Research output: Contribution to journalComment/debate

1 Citation (Scopus)

Abstract

(Developmental Cell 44, 447–459.e1–e5; February 26, 2018) In the originally published version of the article, the Declaration of Interests section did not include a financial interest and patent application. At the time of publication, H.Z. owned 90 shares of Alnylam stock worth approximately $9,000. Figures S3E and S3F were performed in collaboration with Alnylam. In addition, H.Z. and S.Z. hold a patent application entitled “Inhibitory RNA-Based Therapeutics Targeting ANLN for Cancer Treatment (International Patent Application No. PCT/US2017/034142 based on U.S. Serial No. 62/347,803).” The Declaration of Interests section has been updated here and in the article online. This correction does not affect the results in the article or the conclusions of this study. The authors regret this oversight.

Original languageEnglish (US)
Number of pages1
JournalDevelopmental Cell
Volume47
Issue number3
DOIs
StatePublished - Nov 5 2018

Fingerprint

Polyploidy
Liver
Publications
Tumors
Emotions
RNA
Neoplasms
Oncology
Therapeutics

ASJC Scopus subject areas

  • Molecular Biology
  • Biochemistry, Genetics and Molecular Biology(all)
  • Developmental Biology
  • Cell Biology

Cite this

Erratum : The Polyploid State Plays a Tumor-Suppressive Role in the Liver (Developmental Cell (2018) 44(4) (447–459.e5), (S1534580718300108) (10.1016/j.devcel.2018.01.010)). / Zhang, Shuyuan; Zhou, Kejin; Luo, Xin; Li, Lin; Tu, Ho Chou; Sehgal, Alfica; Nguyen, Liem H.; Zhang, Yu; Gopal, Purva; Tarlow, Branden D.; Siegwart, Daniel J; Zhu, Hao.

In: Developmental Cell, Vol. 47, No. 3, 05.11.2018.

Research output: Contribution to journalComment/debate

@article{edb9041bf537445b9a855ce6db388ded,
title = "Erratum: The Polyploid State Plays a Tumor-Suppressive Role in the Liver (Developmental Cell (2018) 44(4) (447–459.e5), (S1534580718300108) (10.1016/j.devcel.2018.01.010))",
abstract = "(Developmental Cell 44, 447–459.e1–e5; February 26, 2018) In the originally published version of the article, the Declaration of Interests section did not include a financial interest and patent application. At the time of publication, H.Z. owned 90 shares of Alnylam stock worth approximately $9,000. Figures S3E and S3F were performed in collaboration with Alnylam. In addition, H.Z. and S.Z. hold a patent application entitled “Inhibitory RNA-Based Therapeutics Targeting ANLN for Cancer Treatment (International Patent Application No. PCT/US2017/034142 based on U.S. Serial No. 62/347,803).” The Declaration of Interests section has been updated here and in the article online. This correction does not affect the results in the article or the conclusions of this study. The authors regret this oversight.",
author = "Shuyuan Zhang and Kejin Zhou and Xin Luo and Lin Li and Tu, {Ho Chou} and Alfica Sehgal and Nguyen, {Liem H.} and Yu Zhang and Purva Gopal and Tarlow, {Branden D.} and Siegwart, {Daniel J} and Hao Zhu",
year = "2018",
month = "11",
day = "5",
doi = "10.1016/j.devcel.2018.10.020",
language = "English (US)",
volume = "47",
journal = "Developmental Cell",
issn = "1534-5807",
publisher = "Cell Press",
number = "3",

}

TY - JOUR

T1 - Erratum

T2 - The Polyploid State Plays a Tumor-Suppressive Role in the Liver (Developmental Cell (2018) 44(4) (447–459.e5), (S1534580718300108) (10.1016/j.devcel.2018.01.010))

AU - Zhang, Shuyuan

AU - Zhou, Kejin

AU - Luo, Xin

AU - Li, Lin

AU - Tu, Ho Chou

AU - Sehgal, Alfica

AU - Nguyen, Liem H.

AU - Zhang, Yu

AU - Gopal, Purva

AU - Tarlow, Branden D.

AU - Siegwart, Daniel J

AU - Zhu, Hao

PY - 2018/11/5

Y1 - 2018/11/5

N2 - (Developmental Cell 44, 447–459.e1–e5; February 26, 2018) In the originally published version of the article, the Declaration of Interests section did not include a financial interest and patent application. At the time of publication, H.Z. owned 90 shares of Alnylam stock worth approximately $9,000. Figures S3E and S3F were performed in collaboration with Alnylam. In addition, H.Z. and S.Z. hold a patent application entitled “Inhibitory RNA-Based Therapeutics Targeting ANLN for Cancer Treatment (International Patent Application No. PCT/US2017/034142 based on U.S. Serial No. 62/347,803).” The Declaration of Interests section has been updated here and in the article online. This correction does not affect the results in the article or the conclusions of this study. The authors regret this oversight.

AB - (Developmental Cell 44, 447–459.e1–e5; February 26, 2018) In the originally published version of the article, the Declaration of Interests section did not include a financial interest and patent application. At the time of publication, H.Z. owned 90 shares of Alnylam stock worth approximately $9,000. Figures S3E and S3F were performed in collaboration with Alnylam. In addition, H.Z. and S.Z. hold a patent application entitled “Inhibitory RNA-Based Therapeutics Targeting ANLN for Cancer Treatment (International Patent Application No. PCT/US2017/034142 based on U.S. Serial No. 62/347,803).” The Declaration of Interests section has been updated here and in the article online. This correction does not affect the results in the article or the conclusions of this study. The authors regret this oversight.

UR - http://www.scopus.com/inward/record.url?scp=85055485910&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055485910&partnerID=8YFLogxK

U2 - 10.1016/j.devcel.2018.10.020

DO - 10.1016/j.devcel.2018.10.020

M3 - Comment/debate

VL - 47

JO - Developmental Cell

JF - Developmental Cell

SN - 1534-5807

IS - 3

ER -